Literature DB >> 23518634

Long-term outcomes after off-pump coronary artery bypass grafting in left ventricular dysfunction.

Toshihiro Fukui1, Minoru Tabata, Shuichiro Takanashi.   

Abstract

PURPOSE: We assessed the long-term clinical, angiographic, and echocardiographic outcomes of patients with left ventricular dysfunction (ejection fraction ≤40%) who underwent isolated off-pump coronary artery bypass grafting.
METHODS: One hundred sixty one patients were included. Mean age was 67.2 ± 11.4 years, and 20 patients (12.4%) were female. Eighty-eight patients (54.7%) were New York Heart Association functional class 3 or 4. Early postoperative and follow-up angiography and echocardiography findings were analyzed, and mid-term survival rates (mean follow-up 40.7 ± 25.6 months) were calculated.
RESULTS: Mean number of distal anastomoses was 4.4 ± 1.3. Bilateral internal thoracic artery grafts were used in 84.5% of patients. Operative mortality was 2.5%. Early patency rate of anastomoses was 98.3%. Early postoperative ejection fraction improved from 33.1 ± 5.6% preoperatively to 36.9 ± 9.5% (p <0.001). Seven-year survival rate was 73.9 ± 5.3%, and freedom from cardiac events rate was 68.5 ± 5.2%. One-year patency rate of anastomoses was 85.8%. Follow-up ejection fraction was 39.1 ± 10.7% (p <0.001).
CONCLUSIONS: Early and long-term outcomes of off-pump coronary artery bypass grafting in patients with left ventricular dysfunction were favorable, including early postoperative and follow-up patency rates of anastomoses and echocardiographic recovery of ejection fraction.

Entities:  

Mesh:

Year:  2013        PMID: 23518634     DOI: 10.5761/atcs.oa.12.02177

Source DB:  PubMed          Journal:  Ann Thorac Cardiovasc Surg        ISSN: 1341-1098            Impact factor:   1.520


  1 in total

1.  Anaortic off-pump bilateral internal mammary grafting in severe left ventricular dysfunction - Case report.

Authors:  Kamales Kumar Saha; Saurab Goel; Ajay Kumar; Kakalee K Saha
Journal:  Indian Heart J       Date:  2015-04-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.